BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12413866)

  • 21. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC.
    Liddle J; Huffman JW; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2223-6. PubMed ID: 9873517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.
    Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK
    Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adamantyl cannabinoids: a novel class of cannabinergic ligands.
    Lu D; Meng Z; Thakur GA; Fan P; Steed J; Tartal CL; Hurst DP; Reggio PH; Deschamps JR; Parrish DA; George C; Järbe TU; Lamb RJ; Makriyannis A
    J Med Chem; 2005 Jul; 48(14):4576-85. PubMed ID: 15999995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
    Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
    Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
    Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols.
    Wilson RS; Martin BR; Dewey WL
    J Med Chem; 1979 Jul; 22(7):879-82. PubMed ID: 448686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of cannabinoid receptors by photoaffinity labelling.
    Burstein SH; Audette CA; Charalambous A; Doyle SA; Guo Y; Hunter SA; Makriyannis A
    Biochem Biophys Res Commun; 1991 Apr; 176(1):492-7. PubMed ID: 1850270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.
    Huffman JW; Zengin G; Wu MJ; Lu J; Hynd G; Bushell K; Thompson AL; Bushell S; Tartal C; Hurst DP; Reggio PH; Selley DE; Cassidy MP; Wiley JL; Martin BR
    Bioorg Med Chem; 2005 Jan; 13(1):89-112. PubMed ID: 15582455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
    Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
    J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tricyclic pyrazoles. Part 1: synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1and CB2 cannabinoid receptors.
    Mussinu JM; Ruiu S; Mulè AC; Pau A; Carai MA; Loriga G; Murineddu G; Pinna GA
    Bioorg Med Chem; 2003 Jan; 11(2):251-63. PubMed ID: 12470719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol.
    Khanolkar AD; Lu D; Fan P; Tian X; Makriyannis A
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2119-24. PubMed ID: 10465529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.
    Hernández M; Berrendero F; Suárez I; García-Gil L; Cebeira M; Mackie K; Ramos JA; Fernández-Ruiz J
    Brain Res; 2000 Feb; 857(1-2):56-65. PubMed ID: 10700552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel probe for the cannabinoid receptor.
    Devane WA; Breuer A; Sheskin T; Järbe TU; Eisen MS; Mechoulam R
    J Med Chem; 1992 May; 35(11):2065-9. PubMed ID: 1317925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
    Huffman JW; Mabon R; Wu MJ; Lu J; Hart R; Hurst DP; Reggio PH; Wiley JL; Martin BR
    Bioorg Med Chem; 2003 Feb; 11(4):539-49. PubMed ID: 12538019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.